RORaquel Ordoñez

Raquel Ordoñez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raquel Ordoñez has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthetic genomic dissection of enhancer context sensitivity and synergy

    by Raquel Ordoñez, André M. Ribeiro-Dos-Santos, Colleen McLoughlin, Gwen Ellis, Hannah J. Ashe, Nerea Berastegui Zufiaurre, Ran Brosh, Milosz Majewski, Kelly Barriball, Brendan Camellato, et al.

    Noncoding disease and trait-associated genetic variation is frequently interpreted in the context of genomic regulatory elements such as DNase I hypersensitive sites (DHSs). But while most DHSs lie within a few kilobases of another DHS, regulatory elements are typically analyzed individually without accounting for their neighbors. Based on our Big-IN technology for scarless genome engineering, we have developed a high-throughput multiplexed delivery pipeline to analyze >100 engineered payloads in hundreds of mouse embryonic stem cell (mESC) clones. We characterize multiple heterotypic DHS combinations from different critical mESC regulator loci, all delivered in a constant chromosomal context replacing the Sox2 Locus Control Region (LCR). We identify widespread examples of context-dependent enhancers which have no activity on their own but can double the activity of a neighboring DHS. We find pervasive context dependencies that depend on the specific DHS pairings. We further show that synergy between neighboring DHSs decays as a characteristic function of distance, with its influence extending up to several kilobases. We fine map this context dependency to the contribution of individual transcription factor recognition sequences. Our approach implicates the specific sequence and architectural features underpinning pervasive genomic context effects, and outlines key directions for modeling the functional impact of noncoding regulatory variation on common human traits and diseases.


  • Open Access

    Mouse genome rewriting and tailoring of three important disease loci

    by Weimin Zhang, Ilona Golynker, Ran Brosh, Alvaro Fajardo, Yinan Zhu, Aleksandra M. Wudzinska, Raquel Ordoñez, André M. Ribeiro-Dos-Santos, Lucia Carrau, Payal Damani-Yokota, et al.

    Genetically engineered mouse models (GEMMs) help us to understand human pathologies and develop new therapies, yet faithfully recapitulating human diseases in mice is challenging. Advances in genomics have highlighted the importance of non-coding regulatory genome sequences, which control spatiotemporal gene expression patterns and splicing in many human diseases1,2. Including regulatory extensive genomic regions, which requires large-scale genome engineering, should enhance the quality of disease modelling. Existing methods set limits on the size and efficiency of DNA delivery, hampering the routine creation of highly informative models that we call genomically rewritten and tailored GEMMs (GREAT-GEMMs). Here we describe ‘mammalian switching antibiotic resistance markers progressively for integration’ (mSwAP-In), a method for efficient genome rewriting in mouse embryonic stem cells. We demonstrate the use of mSwAP-In for iterative genome rewriting of up to 115 kb of a tailored Trp53 locus, as well as for humanization of mice using 116 kb and 180 kb human ACE2 loci. The ACE2 model recapitulated human ACE2 expression patterns and splicing, and notably, presented milder symptoms when challenged with SARS-CoV-2 compared with the existing K18-hACE2 model, thus representing a more human-like model of infection. Finally, we demonstrated serial genome writing by humanizing mouse Tmprss2 biallelically in the ACE2 GREAT-GEMM, highlighting the versatility of mSwAP-In in genome writing.


  • Open Access

    Genomic context sensitizes regulatory elements to genetic disruption

    by Raquel Ordoñez, Weimin Zhang, Gwen Ellis, Yinan Zhu, Hannah J. Ashe, André M. Ribeiro-Dos-Santos, Ran Brosh, Emily Huang, Megan S. Hogan, Jef D. Boeke, et al.

    SUMMARY: Enhancer function is frequently investigated piecemeal using truncated reporter assays or single deletion analysis. Thus it remains unclear to what extent enhancer function at native loci relies on surrounding genomic context. Using the Big-IN technology for targeted integration of large DNAs, we analyzed the regulatory architecture of the murine Igf2 / H19 locus, a paradigmatic model of enhancer selectivity. We assembled payloads containing a 157-kb functional Igf2 / H19 locus and engineered mutations to genetically direct CTCF occupancy at the imprinting control region (ICR) that switches the target gene of the H19 enhancer cluster. Contrasting activity of payloads delivered at the endogenous Igf2 / H19 locus or ectopically at Hprt revealed that the Igf2 / H19 locus includes additional, previously unknown long-range regulatory elements. Exchanging components of the Igf2 / H19 locus with the well-studied Sox2 locus showed that the H19 enhancer cluster functioned poorly out of context, and required its native surroundings to activate Sox2 expression. Conversely, the Sox2 locus control region (LCR) could activate both Igf2 and H19 outside its native context, but its activity was only partially modulated by CTCF occupancy at the ICR. Analysis of regulatory DNA actuation across different cell types revealed that, while the H19 enhancers are tightly coordinated within their native locus, the Sox2 LCR acts more independently. We show that these enhancer clusters typify broader classes of loci genome-wide. Our results show that unexpected dependencies may influence even the most studied functional elements, and our synthetic regulatory genomics approach permits large-scale manipulation of complete loci to investigate the relationship between locus architecture and function. HIGHLIGHTS: Composite enhancer elements are subject to genomic context effects mapped to a specific architecture of their endogenous loci. Igf2/H19 expression is affected by long-range regulatory elements beyond the canonically defined locus, and the H19 enhancer cluster in particular relies on the surrounding context at its endogenous locus. The Sox2 LCR functions as an autonomous enhancer without requiring additional surrounding context. The influence of genomic context is buffered at intact loci, but manifests more strongly as key regulatory elements are deleted or repositioned.


  • Open Access

    Synthetic regulatory genomics uncovers enhancer context dependence at the Sox2 locus

    by Ran Brosh, Camila Coelho, André M. Ribeiro-Dos-Santos, Gwen Ellis, Megan S. Hogan, Hannah J. Ashe, Nicolette Somogyi, Raquel Ordoñez, Raven D. Luther, Emily Huang, et al.

    Expression of Sox2 in mouse embryonic stem cells (mESCs) depends on a distal regulatory cluster of DNase I hypersensitive sites (DHSs), but their individual contributions and degree of independence remain a mystery. Here, we comprehensively analyze the regulatory architecture of Sox2 at its endogenous locus using Big-IN to scarlessly integrate DNA payloads ranging up to 143 kb. We analyzed 83 payloads incorporating deletions, rearrangements, and inversions affecting single or multiple DHSs, as well as surgical alterations to transcription factor (TF) recognition sequences. Multiple mESC clones were derived for each payload, sequence-verified, and analyzed to establish the necessity and sufficiency of genomic features for Sox2 expression. We found that two LCR DHSs comprising a handful of key TF recognition sequences were each sufficient to autonomously sustain significant expression in mESCs. However, three additional LCR DHSs were entirely context-dependent, in that they showed no activity alone but could dramatically augment activity of the core DHSs. Our synthetic regulatory genomics approach demonstrates that composite regulatory elements can be reduced to a tractable set of essential sequence features, and is readily scalable to investigate regulatory architecture at other key loci genome-wide.


  • Open Access

    Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts

    by Ane Amundarain, Luis V. Valcárcel, Raquel Ordoñez, Leire Garate, Estíbaliz Miranda, Xabier Cendoya, Arantxa Carrasco‐Leon, María José Calasanz, Bruno Paiva, Cem Meydan, et al.


  • Open Access

    Transcriptional regulation of HSCs in Aging and MDS reveals DDIT3 as a Potential Driver of Dyserythropoiesis

    by Nerea Berastegui, Marina Ainciburu, Juan P. Romero, Ana Alfonso-Pierola, Céline Philippe, Amaia Vilas, Patxi San Martin, Raquel Ordoñez, Diego Alignani, Sarai Sarvide, et al.

    Myelodysplastic syndromes (MDS) are hematopoietic stem cell (HSC) malignancies characterized by ineffective hematopoiesis, with increased incidence in elderly individuals. In this work, we analyzed the transcriptome of human HSCs purified from young and elderly healthy donors, as well as MDS patients, identifying transcriptional alterations following eight different patterns of expression. While aging-associated lesions seemed to predispose HSCs to myeloid transformation, disease-specific alterations may trigger MDS development. Among MDS-specific lesions, we detected the upregulation of the transcription factor DDIT3 . Overexpression of DDIT3 in human healthy HSCs induced an MDS-like transcriptional state, and a delay in erythropoiesis. Such effect was associated with downregulation of transcription factors required for normal erythropoiesis, and with a failure in the activation of their transcriptional programs. Moreover, DDIT3 knockdown in CD34 + cells from MDS patients with anemia was able to restore erythropoiesis. These results identify DDIT3 as a driver of dyserythropoiesis, and a potential therapeutic target to restore the inefficient erythropoiesis characterizing MDS patients. STATEMENT OF SIGNIFICANCE: This study defines how human aging and MDS development are characterized by transcriptional alterations in HSCs that follow different patterns, some of which may contribute to myeloid transformation. Among them, we demonstrate how MDS-specific upregulation of DDIT3 in HSCs induces dyserythropoiesis, while its knockdown in HSPCs from MDS patients restores proper erythroid differentiation.